Skip to main content
Nature Portfolio logoLink to Nature Portfolio
. 2020 Feb 28;27(3):182. doi: 10.1038/s41434-020-0135-y

Retraction Note: Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors

Y Zhao 1, D H Lam 1, J Yang 2, J Lin 1, C K Tham 3, W H Ng 4, S Wang 1,2,✉
PMCID: PMC8076021  PMID: 32111977

Retraction Note to: Gene Therapy

10.1038/gt.2011.82.

The editor has retracted this article [1] following an investigation by Agency for Science, Technology and Research (A*STAR), Institute of Bioengineering and Nanotechnology, Singapore, which found evidence of fabricated animal survival data presented in Fig. 7C in the article to make the results statistically significant. DHL, JY, JL, CKT, WHN, and SW agree to this retraction. YZ has agreed to this retraction but not to the wording of this retraction notice.

Footnotes

The original article can be found online at 10.1038/gt.2011.82.

References

  • 1.Zhao Y, Lam D, Yang J, et al. Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors. Gene Ther. 2012;19:189–200. doi: 10.1038/gt.2011.82. [DOI] [PubMed] [Google Scholar]

Articles from Gene Therapy are provided here courtesy of Nature Publishing Group

RESOURCES